Zimbabwe has declined a major US healthcare agreement valued at 367 million US dollars (£272m) over five years due to the United States' insistence on sensitive data.
This move came to light after a internal memorandum from December was leaked, indicating that Head of State Emmerson Mnangagwa believed the agreement was "skewed".
A government spokesman later stated that the United States was seeking health data for research and profit but was unwilling to share the benefits from future treatments.
"We must now begin the difficult and regrettable process of scaling back our health assistance in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the United States had donated over $1.9bn in health funding to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has urged more dialogue to find a agreement acceptable to all parties so the nation's critical HIV programme can be sustained.
Broader Background
This rejection comes after a comparable situation in neighbouring Kenya, where a court halted a similar deal with the US following concerns were filed about the safety of Kenyans' health data.
Since resuming the presidency recently, US President Donald Trump has drastically cut foreign aid and closed the US Agency for International Development (USAID).
The agency had managed assistance for the American government, but Trump claimed its expenditure was "wasteful" and his government was seeking government-to-government deals to enhance openness and responsibility.
As per statements, Sixteen African countries have so far signed these new health pacts, representing more than $18.3bn of fresh investment.
Specifics of the Rejected Agreement
The money for Zimbabwe was intended to gone towards "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this cooperation would have delivered significant benefits for the people of Zimbabwe, particularly the 1.2 million currently receiving antiretroviral therapy through American-funded programmes," Tremont said.
However, government spokesperson Nick Mangwana said the arrangement was "asymmetrical".
"The proposal required Zimbabwe to surrender its genetic material and health information over an extended period, with no corresponding assurance of benefiting from any scientific breakthroughs – such as new medicines or tests – that might result from that shared data," Mangwana explained.
"Effectively, our country would provide the basic resources for medical research with no assurance that the final treatments would be available to our citizens if a new health crisis arise."
National Interest and International Frameworks
Mangwana further noted that the American exit from the World Health Organization (WHO) and its pursuit of bilateral deals were undermining structures already established via the global organization.
Mangwana gave as an example its Pandemic Benefit-Sharing scheme created to manage future global health emergencies.
"This mechanism is designed to guarantee that when a nation provides its samples, the resulting advantages – such as medicines and cures – are distributed fairly, not commercialised solely by those with the resources to develop them."
These objections over the US deal "must not be interpreted as opposition to America," Mangwana stressed.
"We welcome ongoing dialogue with our American counterparts on how subsequent collaboration could be structured in a way that respects the sovereignty and dignity of each country."
Medical Community Reaction
Medical experts said it understood the official position, but urged that talks must proceed considering a large portion of the nation's Aids initiatives relied on international support.
"Where technical issues arise, including those relating to information security or implementation frameworks, these can often be addressed through detailed discussion and negotiated safeguards," the group added.
This impasse underscores the continuing debate between receiving vital foreign assistance and safeguarding a country's data in an ever more data-driven world.